Analyst Ratings for Corcept Therapeutics (CORT)
CORT Rating Summary
CORT Price Target Summary
- Highest: $165.00 (Piper Sandler)
- Lowest: $50.00 (Wolfe Research)
- Average: $127.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$127.67 (+12.6%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
Avg. $ Target:
$127.67 (+12.6%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | Truist Securities | Srikripa Devarakonda | New Coverage | Buy (N/A) |
164.00 (N/A) |
117.17 (113.38) |
-3.23% | Details |
| 7/27/2026 | Wolfe Research | Kalpit Patel | Downgrade | Underperform (Peerperform) |
50.00 (N/A) |
96.66 (113.38) |
17.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
